News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mystic Pharmaceuticals Receives Multiple U.S. Patent Office Notices of Allowance on Drug Delivery Platform Technologies


9/17/2013 11:02:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, announced today it has received two Notices of Allowance from the U.S. Patent Office for its “Unit Dose Drug Delivery Platform” (serial number 12/851,524) and Piercing Device for Drug Delivery Systems (serial number 13/149,584) patent applications. These patents expand Mystic’s novel VersiDoser® and VRx2™ delivery platforms enabling the development of patient-centric pharmaceutical products. Mystic is applying its innovative delivery technology to develop therapeutics for the treatment of ocular, CNS, neurodegenerative and infectious diseases affecting large global populations.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES